Missouri Seed-to-Sale Traceability Info

Here is an overview of the rules and regulations that can be addressed using seed to sale cannabis tracking software. For the full set of rules and regulations, please click here.

• (4) Facility Operation, Policies, and Procedures
  • (G) All cultivation, infused products manufacturing, dispensary, testing, and transportation facilities shall use a department-certified seed-to-sale tracking system to track medical marijuana from seed or immature plant stage until the medical marijuana is purchased by a qualifying patient or primary caregiver or destroyed.
    • 1. Each facility shall designate in writing a facility agent who is generally responsible for the inventory control system for that facility.
    • 2. Each facility shall document each day’s beginning inventory, harvests, acquisitions, sales, disbursements, disposals, and ending inventory, which must indicate, at least:
      • A. For every quantity of medical marijuana in the form of plants, flowers, trim, or seeds–
        • (I) Number of plants, including cuttings;
        • (II) Weight of flowers, measured in grams;
        • (III) Weight of trim, measured in grams; and
        • (IV) Weight of seeds, measured in grams.
      • B. For each batch of medical marijuana cultivated or processed;
        • (I) The batch number, harvest lot number, and process lot number, as applicable;
        • (II) Whether the batch originated from medical marijuana seeds or cuttings;
        • (III) The strain of the medical marijuana seeds or cuttings planted;
        • (IV) The number of medical marijuana seeds or cuttings planted;
        • (V) The date on which the medical marijuana seeds or cuttings were planted;
        • (VI) A list of all chemical additives used in cultivation, including, without limitation, pesticides, fertilizers, and other agricultural chemicals;
        • (VII) The number of medical marijuana plants grown to maturity;
        • (VIII) Harvest information, including—
          • (a) The date of harvest;
          • (b) The final yield weight of medical marijuana, in grams; and
          • (c) The name and identifying number of the facility agent who was responsible for that harvest;
        • (VIX) The disposal of medical marijuana that is not usable medical marijuana, including:
          • (a) A description of and reason for the medical marijuana being disposed, including the weight in grams or ounces of the disposed medical marijuana and, if applicable, the number of failed or otherwise unusable medical marijuana plants;
          • (b) The date of disposal;
          • (c) The harvest lot number and/or process lot number of the disposed marijuana;
          • (d) Confirmation that the marijuana was rendered unusable before disposal, including the time and location of rendering that marijuana unusable;
          • (e) The method of rendering the marijuana unusable and method of disposal; and
          • (f) The name and identifying numbers of at least two (2) facility agents present at the time of disposal.
      • C. When acquiring medical marijuana from or selling it to another facility:
        • (I) The amount, strain, batch number, harvest lot number, and process lot number of the marijuana, as applicable;
        • (II) The weight of the medical marijuana, which shall be recorded—
          • (a) For dried, unprocessed medical marijuana, in ounces or grams;
          • (b) For concentrates, in grams;
          • (c) For infused products, by milligrams of tetrahydrocannabinol (THC);
        • (III) The name of the facility selling the medical marijuana;
        • (IV) The name of the facility acquiring the medical marijuana;
        • (V) The names and identifying numbers of the facility agents who were responsible for the sale and acquisition of the medical marijuana; and
        • (VI) The date of the sale/acquisition.
      • D. When selling medical marijuana to a patient or primary caregiver:
        • (I) The amount, strain, batch number, harvest lot number, and process lot number of the medical marijuana, as applicable;
        • (II) The weight of the medical marijuana, which shall be recorded—
          • (a) For dried, unprocessed medical marijuana, in ounces or grams;
          • (b) For concentrates, in grams;
          • (c) For infused products, by milligrams of THC;
        • (III) The name of the facility selling the medical marijuana;
        • (IV) The name of the patient or primary caregiver acquiring the medical marijuana;
        • (V) The name and identifying numbers of the facility agents who were responsible for the sale of the medical marijuana;
        • (VI) The date of the sale.
      • E. When transporting medical marijuana between facilities or from a facility to a patient or caregiver:
        • (I) The amount, strain, batch number, harvest lot number, and process lot number of the marijuana, as applicable;
        • (II) The weight of the medical marijuana, which shall be recorded—
          • (a) For dried, unprocessed medical marijuana, in ounces or grams;
          • (b) For concentrates, in grams;
          • (c) For infused products, by milligrams of tetrahydrocannabinol (THC);
          • (III) The name of the facility from which medical marijuana departs;
          • (IV) The date on which the medical marijuana departed;
          • (V) The name of the facility to which the medical marijuana is delivered, if applicable;
          • (VI) The name of the patient or primary caregiver acquiring the medical marijuana, if applicable;
          • (VII) The date on which the medical marijuana was delivered to a facility, patient, or primary caregiver; and
          • (VIII) The names and identifying numbers of the facility agents who are responsible for the transportation of the medical marijuana.
    • 3. Each infused product manufacturing facility shall:
      • A. Establish and maintain a perpetual inventory system that documents the flow of materials through the manufacturing process;
      • B. Establish procedures to reconcile the raw material used to the finished product on the basis of each process lot. Significant variances must be documented, investigated by management personnel, and reported to the department and to the facility that ordered the infused product within twenty-four (24) hours of discovering the variances; and
      • C. Provide for quarterly physical inventory counts to be performed by facility employees who do not participate in the manufacturing process, which shall be reconciled to the perpetual inventory records. Significant variances must be documented, investigated by management personnel, and reported to the department within twenty-four (24) hours of discovering the variances.
    • 4. Each dispensary facility shall be responsible for ensuring that every amount of medical marijuana sold or disbursed to a qualifying patient or primary caregiver is recorded in the seedto-sale tracking system as a purchase by or on behalf of the applicable qualifying patient. Amounts of medical marijuana shall be recorded—
      • A. For dried, unprocessed marijuana, in ounces or grams;
      • B. For concentrates, in grams;
      • C. For infused products, by milligrams of THC.
    • 5. If a facility identifies a reduction in the amount of medical marijuana in the inventory of the facility, the facility must document where in the facility’s processes the loss has occurred, if possible, and take and document corrective action. If the reduction in the amount of medical marijuana in the inventory of the facility is due to suspected criminal activity by a facility agent, the facility shall report the facility agent to the department and to the appropriate law enforcement agencies within twenty-four (24) hours of discovering the suspected criminal activity.
    • 6. A medical marijuana facility shall maintain all records required by this subsection for at least five (5) years.
• (H) All cultivation, infused products manufacturing, and dispensary facilities shall ensure the security of medical marijuana and facility employees by taking at least the following measures.
• (J) All cultivation, infused products manufacturing, and dispensary facilities shall ensure that all medical marijuana is packaged and labeled in a manner consistent with the following
  • 1. Facilities shall not manufacture, package, or label marijuana–
    • A. In a false or misleading manner;
    • B. In any manner designed to cause confusion between a marijuana product and any product not containing marijuana; or
    • C. In any manner designed to appeal to a minor.
  • 2. Marijuana and marijuana-infused products shall be sold in containers clearly and conspicuously labeled, in a font size at least as large as the largest other font size used on the package, with:
    • A. “Marijuana” or a “Marijuana-infused Product;” and
    • B. “Warning: Cognitive and physical impairment may result from the use of Marijuana.”
  • 3. Any marijuana or marijuana-infused products packaged for retail sale before delivery to a dispensary must be packaged in opaque, re-sealable packaging designed or constructed to be significantly difficult for children under five (5) years of age to open but not normally difficult for adults to use properly. Any marijuana or marijuana-infused products not packaged for retail sale before delivery to a dispensary must be packaged by the dispensary upon sale to a qualifying patient or primary caregiver in opaque, re-sealable packaging designed or constructed to be significantly difficult for children under five (5) years of age to open but not normally difficult for adults to use properly. All edible marijuana-infused products must be packaged for retail by the infused-products manufacturer before sale to a dispensary.
  • 4. Marijuana and marijuana-infused products shall bear a label displaying the following information, in the following order:
    • A. The total weight of the marijuana included in the package;
      • (I) For dried, unprocessed marijuana, weight shall be listed in ounces or grams;
      • (II) For concentrates, weight shall be listed in grams;
      • (III) For infused products, weight shall be listed by milligrams of THC;
    • B. Dosage amounts, instructions for use, and estimated length of time the dosage will have an effect;
    • C. The THC, tetrahydrocannabinol acid, cannabidiol, cannabidiol acid, and cannabinol concentration per dosage;
    • D. All active and inactive ingredients, which shall not include groupings of ingredients that obscure the actual ingredients, such as “proprietary blend” or “spices;”
    • E. The name of the strain or strains of marijuana in the package, the name and address of the cultivating facility from which the marijuana in the package originated, and the name and address of the infused-product manufacturer, if applicable; and
    • F. A “best if used by” date.
  • 5. No branding, artwork, or other information or design elements included on marijuana or marijuana-infused products shall be placed in such a way as to obscure any of the information required by this section.
  • 6. Marijuana and marijuana-infused product packaging shall not include claims of health benefits but may include health warnings.
• (K) Cultivation, manufacturing, dispensary, and testing facilities that transport medical marijuana must also comply with 19 CSR 30-95.100(D) in doing so.

For the latest cannabis-related legislative updates on Missouri, check out our Cannabis Bill Tracker!

Please note that this page is meant to serve as a resource and not an official set of requirements. For the official rules and regulations, please click here.